Nanoimmunocel Inc
- Biotech or pharma, therapeutic R&D
NANOIMMUNOCEL Inc. is a potential clinical-stage US biotechnology company pioneering a differentiated pipeline of multispecific antibodies (MsAbs) designed to overcome the limitations of conventional immunotherapies. Our modular MsAb platform integrates advanced protein engineering, tumor microenvironment targeting, and immune cell redirection to enable potent, selective, and durable antitumor responses across various solid tumors and inflammatory disorders.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}